Registry for healthy adults at Mayo Clinic with congenital heart disease
Control Population for the Mayo Clinic Adult Congenital Heart Disease Registry
This study is setting up a registry of healthy adults with congenital heart disease at Mayo Clinic to help understand their health outcomes better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 75 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT05773300 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a control population registry for adults with congenital heart disease at the Mayo Clinic. It will collect comparative data to enhance understanding of health outcomes in this specific patient group. Participants will be screened based on specific eligibility criteria, including BMI, blood pressure, and absence of cardiovascular disease. The study will help establish a baseline for future research and treatment comparisons.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults with a BMI of 30 or less and no history of cardiovascular disease.
Not a fit: Patients with a history of cardiovascular disease or significant orthopedic limitations may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights that improve the management and treatment of adults with congenital heart disease.
How similar studies have performed: Other studies have successfully utilized registries to improve understanding of congenital heart disease outcomes, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI ≤ 30. * No current cardiac medications. * Systolic BP ≤ 140 mmHg. * Diastolic BP ≤ 90 mmHg. * Capacity to consent. Exclusion Criteria: * To be assessed via EMR screening. * Patient confirmation during screening visit. * Screening tests as applicable. * History of cardiovascular disease. eGFR \< 30. * Current orthopedic limitations.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic Minnesota — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Alexander Egbe, MBBS, MPH — Mayo Clinic
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.